Skip to content

Prevention of leprosy using rifampicin as chemoprophylaxis.

M.I. Bakker, M. Hatta, A. Kwenang, B.H.B. Benthem, S.M. van Beers, P.R. Klatser, L. Oskam

Leprosy is an infectious disease caused by Mycobacterium leprae. Multidrug treatment (MDT) was introduced by the World Health Organization (WHO) in 1982 and was seen as an instrument for the elimination of leprosy as a public health problem, defined as a national prevalence less than 1/10,000. However, even after 20 years of MDT, case detection rates (CDRs) are not decreasing, indicating that patients are probably not the only source of transmission; subclinically infected persons and contacts of patients have also been implicated.Therefore, it is necessary to examine interventions which include these groups of potentially infectious persons.

Related work

  • Long Term Collaboration with Netherlands Leprosy Relief

    • Institute
    • Project

    In a long-term collaboration, KIT Royal Tropical Institute and the Netherlands Leprosy Relief (NLR) have been working to reduce leprosy, whilst improving methods for its evaluation and study. This has resulted in significant research contribution and global policy setting, as well as country-level improvements in leprosy detection and control. Furthering the agenda in global leprosy […]

  • The INFIR Cohort Study: assessment of sensory and motor neuropathy in leprosy at baseline

    • Institute
    • Publication

    Leprosy is known for the neuropathy it causes. Different methods have been used to detect leprosy-related nerve function impairment (NFI).More sophisticated methods for assessing nerve function such as vibrometry, laser Doppler flowmetry and thermal threshold testing have been shown to detect different modalities of leprous neuropathy. However, it is not known which of these testing […]